Cooper Companies | COO - 当期純利益

株価
63.10
毎日の変更
1.76 2.87%
毎月
-11.75%
毎年
-22.23%
Q2 予測
63.04




当期純利益 変化する 日付
Abbott USD 1.08B 699M 2026-03
Align Technology USD 112.77M 22.99M 2026-03
AtriCure USD 1.76M 2.02M 2025-12
Avanos Medical USD -1.3M 100K 2025-12
Bausch Health Companies USD -1.42B 1.31B 2026-03
Baxter International USD -1.13B 1.08B 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 1.34B 669M 2026-03
Cooper Companies USD 130.8M 46.2M 2025-12
Dentsply International USD -146M 281M 2025-12
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Globus Medical USD 140.59M 21.63M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 821.5M 26.7M 2026-03
J&J USD 5.24B 119M 2026-03
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 38.01M 10.25M 2025-12
Novartis USD 2.41B 1.52B 2025-12
ResMed USD 392.59M 44.06M 2025-12
STAAR Surgical USD -18.31M 27.19M 2025-12
Steris USD 192.9M 1000K 2025-12
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Utah Medical Products USD 2.57M 445K 2025-12
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03